Your browser doesn't support javascript.
loading
A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.
Goyal, Lipika; Zheng, Hui; Yurgelun, Matthew B; Abrams, Thomas A; Allen, Jill N; Cleary, James M; Knowles, Michelle; Regan, Eileen; Reardon, Amanda; Khachatryan, Anna; Jain, Rakesh K; Nardi, Valentina; Borger, Darrell R; Duda, Dan G; Zhu, Andrew X.
Afiliação
  • Goyal L; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Zheng H; Harvard Medical School, Boston, Massachusetts.
  • Yurgelun MB; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Abrams TA; Harvard Medical School, Boston, Massachusetts.
  • Allen JN; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cleary JM; Harvard Medical School, Boston, Massachusetts.
  • Knowles M; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Regan E; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Reardon A; Harvard Medical School, Boston, Massachusetts.
  • Khachatryan A; Harvard Medical School, Boston, Massachusetts.
  • Jain RK; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Nardi V; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Borger DR; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Duda DG; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Zhu AX; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Cancer ; 123(11): 1979-1988, 2017 06 01.
Article em En | MEDLINE | ID: mdl-28192597

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias dos Ductos Biliares / Colangiocarcinoma / Inibidores de Proteínas Quinases / Anilidas Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias dos Ductos Biliares / Colangiocarcinoma / Inibidores de Proteínas Quinases / Anilidas Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos